Tan Joy H, Al Abed Amr, Brock James A
Prince of Wales Medical Research Institute, University of New South Wales, Barker Street, Randwick, NSW 2031, Australia.
J Physiol. 2007 Jun 1;581(Pt 2):757-65. doi: 10.1113/jphysiol.2007.129536. Epub 2007 Mar 22.
In rat tail artery, activation of postjunctional alpha(2)-adrenoceptors by noradrenaline (NA) released from sympathetic axons produces a slow depolarization (NAD) of the smooth muscle through a decrease in K(+) conductance. In this study we used intracellular recording to investigate whether the K(+) channel involved is the ATP-sensitive K(+) (K(ATP)) channel. Changes in membrane resistance were monitored by measuring the time constant of decay of excitatory junction potentials. The K(ATP) channel blockers, glibenclamide (10 microm) and PNU 37883A (5 microm), depolarized the smooth muscle and increased membrane resistance. Conversely, the K(ATP) channel openers, pinacidil (0.1 and 0.5 microm) and levcromakalim (0.1 microm), hyperpolarized the smooth muscle and decreased membrane resistance. Activation of K(ATP) channels with calcitonin gene-related peptide (CGRP; 10 nM) also hyperpolarized the smooth muscle and decreased membrane resistance. The NAD was abolished by both glibenclamide and PNU 37883A but was potentiated by CGRP. However, unlike CGRP, the directly acting K(ATP) channel openers, pinacidil and levcromakalim, inhibited the NAD. The effects of other K(+) channel blockers were also determined. A high concentration of Ba(2+)(1 mM), which would be expected to block K(ATP) channels, abolished the NAD, whereas teteraethylammonium (1 mM) and 4-aminopyridine (1 mM) increased its amplitude. Apamin (0.5 microm) and a lower concentration of Ba(2+) (0.1 mM) did not affect the NAD. These findings indicate that activation of alpha(2)-adrenoceptors by neurally released NA depolarizes the membrane of vascular smooth muscle by inhibiting K(ATP) channels open in the resting membrane.
在大鼠尾动脉中,交感神经轴突释放的去甲肾上腺素(NA)激活节后α₂肾上腺素能受体,通过降低钾离子电导使平滑肌产生缓慢去极化(NAD)。在本研究中,我们采用细胞内记录法来研究所涉及的钾离子通道是否为ATP敏感性钾离子(KATP)通道。通过测量兴奋性接头电位的衰减时间常数来监测膜电阻的变化。KATP通道阻滞剂格列本脲(10微摩尔)和PNU 37883A(5微摩尔)使平滑肌去极化并增加膜电阻。相反,KATP通道开放剂吡那地尔(0.1和0.5微摩尔)和左旋克罗卡林(0.1微摩尔)使平滑肌超极化并降低膜电阻。降钙素基因相关肽(CGRP;10纳摩尔)激活KATP通道也使平滑肌超极化并降低膜电阻。格列本脲和PNU 37883A均消除了NAD,但CGRP增强了NAD。然而,与CGRP不同,直接作用的KATP通道开放剂吡那地尔和左旋克罗卡林抑制了NAD。还测定了其他钾离子通道阻滞剂的作用。高浓度的钡离子(1毫摩尔)预期会阻断KATP通道,消除了NAD,而四乙铵(1毫摩尔)和4-氨基吡啶(1毫摩尔)增加了其幅度。蜂毒明肽(0.5微摩尔)和较低浓度的钡离子(0.1毫摩尔)不影响NAD。这些发现表明,神经释放的NA激活α₂肾上腺素能受体通过抑制静息膜中开放的KATP通道使血管平滑肌膜去极化。